Related references
Note: Only part of the references are listed.Risk factors for predicting progression from mild cognitive impairment to Alzheimer's disease: a systematic review and meta-analysis of cohort studies
Jie-Qiong Li et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
NIA-AA staging of preclinical Alzheimer disease: discordance and concordance of CSF and imaging biomarkers
Stephanie J. B. Vos et al.
NEUROBIOLOGY OF AGING (2016)
Heterogeneity in Suspected Non-Alzheimer Disease Pathophysiology Among Clinically Normal Older Individuals
Elizabeth C. Mormino et al.
JAMA NEUROLOGY (2016)
Cause of Suspected Non-Alzheimer Disease Pathophysiology If Not Tau Pathology, Then What?
Sylvia Villeneuve
JAMA NEUROLOGY (2016)
Longitudinal β-Amyloid Deposition and Hippocampal Volume in Preclinical Alzheimer Disease and Suspected Non-Alzheimer Disease Pathophysiology
Brian A. Gordon et al.
JAMA NEUROLOGY (2016)
Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis
Kirsten L. Viola et al.
ACTA NEUROPATHOLOGICA (2015)
Episodic memory in normal aging and Alzheimer disease: Insights from imaging and behavioral studies
D. Tromp et al.
AGEING RESEARCH REVIEWS (2015)
Hippocampal sclerosis and TDP-43 pathology in aging and Alzheimer disease
Sukriti Nag et al.
ANNALS OF NEUROLOGY (2015)
Mild cognitive impairment with suspected nonamyloid pathology (SNAP) Prediction of progression
Anna Caroli et al.
NEUROLOGY (2015)
Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohort
Maartje I. Kester et al.
ALZHEIMERS RESEARCH & THERAPY (2015)
The Role of Tau Oligomers in the Onset of Alzheimer's Disease Neuropathology
Maria del Carmen Cardenas-Aguayo et al.
ACS CHEMICAL NEUROSCIENCE (2014)
A framework to understand the variations of PSD-95 expression in brain aging and in Alzheimer's disease
Armand Savioz et al.
AGEING RESEARCH REVIEWS (2014)
Is synaptic loss a unique hallmark of Alzheimer's disease?
Stephen W. Scheff et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Harmonized diagnostic criteria for Alzheimer's disease: recommendations
J. C. Morris et al.
JOURNAL OF INTERNAL MEDICINE (2014)
Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014
L. S. Schneider et al.
JOURNAL OF INTERNAL MEDICINE (2014)
Quantification of the Brain Proteome in Alzheimer's Disease Using Multiplexed Mass Spectrometry
Sravani Musunuri et al.
JOURNAL OF PROTEOME RESEARCH (2014)
Disentangling the effects of age and APOE on neuropathology and late life cognitive decline
Lei Yu et al.
NEUROBIOLOGY OF AGING (2014)
Synaptic gene dysregulation within hippocampal CA1 pyramidal neurons in mild cognitive impairment
Scott E. Counts et al.
NEUROPHARMACOLOGY (2014)
Interaction of transactive response DNA binding protein 43 with nuclear factor kappa B in mild cognitive impairment with episodic memory deficits
Yasuyuki Ohta et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)
Overview and Findings from the Religious Orders Study
David A. Bennett et al.
Current Alzheimer Research (2013)
PAK Inactivation Impairs Social Recognition in 3xTg-AD Mice without Increasing Brain Deposition of Tau and Aβ
Dany Arsenault et al.
JOURNAL OF NEUROSCIENCE (2013)
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Chia-Chan Liu et al.
NATURE REVIEWS NEUROLOGY (2013)
SYNAPTIC CHANGES IN ALZHEIMER'S DISEASE AND ITS MODELS
J. Pozueta et al.
NEUROSCIENCE (2013)
Pharmacological recommendations for the symptomatic treatment of dementia: the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012
Nathan Herrmann et al.
Alzheimers Research & Therapy (2013)
TDP-43 Pathology, Cognitive Decline, and Dementia in Old Age
Robert S. Wilson et al.
JAMA NEUROLOGY (2013)
The Potential Use of Hormone-Based Therapeutics for the Treatment of Alzheimers Disease
Jenna C. Carroll et al.
Current Alzheimer Research (2012)
Clinical utility of neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis
Petra Dunkel et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
Peter T. Nelson et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)
Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010
Thomas G. Beach et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)
Hippocampal Drebrin Loss in Mild Cognitive Impairment
Scott E. Counts et al.
NEURODEGENERATIVE DISEASES (2012)
APOE modifies the association between A beta load and cognition in cognitively normal older adults
K. Kantarci et al.
NEUROLOGY (2012)
ANALYSIS OF SNAP25 mRNA EXPRESSION AND PROMOTER DNA METHYLATION IN BRAIN AREAS OF ALZHEIMER'S DISEASE PATIENTS
T. K. Furuya et al.
NEUROSCIENCE (2012)
Pharmacotherapies for Alzheimer's disease: Beyond cholinesterase inhibitors
Haythum O. Tayeb et al.
PHARMACOLOGY & THERAPEUTICS (2012)
Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer's disease
Pamela E. Potter et al.
ACTA NEUROPATHOLOGICA (2011)
What the Halted Phase III γ-Secretase Inhibitor Trial May (or May Not) Be Telling Us
Nina F. Schor
ANNALS OF NEUROLOGY (2011)
被撤回的出版物: Disturbed Neurotransmitter Transporter Expression in Alzheimer's Disease Brain (Retracted article. See vol. 55, pg. 445, 2016)
Kevin H. Chen et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
TAR-DNA binding protein-43 and alterations in the hippocampus
Tuomas Rauramaa et al.
JOURNAL OF NEURAL TRANSMISSION (2011)
Accumulation of Transactive Response DNA Binding Protein 43 in Mild Cognitive Impairment and Alzheimer Disease
Cyntia Tremblay et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)
Resolving controversies on the path to Alzheimer's therapeutics
Dennis J. Selkoe
NATURE MEDICINE (2011)
Anti-Aβ Therapeutics in Alzheimer's Disease: The Need for a Paradigm Shift
Todd E. Golde et al.
NEURON (2011)
Mild Cognitive Impairment in the Elderly is Associated with Volume Loss of the Cholinergic Basal Forebrain Region
Kathrin Muth et al.
BIOLOGICAL PSYCHIATRY (2010)
Revising the definition of Alzheimer's disease: a new lexicon
Bruno Dubois et al.
LANCET NEUROLOGY (2010)
Increased amyloidogenic processing of transgenic human APP in X11-like deficient mouse brain
Maho Kondo et al.
MOLECULAR NEURODEGENERATION (2010)
Subregions of the inferior parietal lobule are affected in the progression to Alzheimer's disease
Sarah J. Greene et al.
NEUROBIOLOGY OF AGING (2010)
The Neuropathology of Probable Alzheimer Disease and Mild Cognitive Impairment
Julie A. Schneider et al.
ANNALS OF NEUROLOGY (2009)
X11β rescues memory and long-term potentiation deficits in Alzheimer's disease APPswe Tg2576 mice
Jacqueline C. Mitchell et al.
HUMAN MOLECULAR GENETICS (2009)
Sirtuin 1 Reduction Parallels the Accumulation of Tau in Alzheimer Disease
Carl Julien et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Neuropathology and Cognitive Impairment in Alzheimer Disease: A Complex but Coherent Relationship
Peter T. Nelson et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Regulation of Amyloid β-Protein Precursor by Phosphorylation and Protein Interactions
Toshiharu Suzuki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
X11 Proteins Regulate the Translocation of Amyloid β-Protein Precursor (APP) into Detergent-resistant Membrane and Suppress the Amyloidogenic Cleavage of APP by β-Site-cleaving Enzyme in Brain
Yuhki Saito et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The parietal cortex and episodic memory: an attentional account
Roberto Cabeza et al.
NATURE REVIEWS NEUROSCIENCE (2008)
In vivo SPECT imaging of vesicular acetylcholine transporter using [123I]-IBVM in early Alzheimer's disease
J. Mazere et al.
NEUROIMAGE (2008)
The β-propensity of Tau determines aggregation and synaptic loss in inducible mouse models of tauopathy
Katrin Eckermann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Superior frontal cortex cholinergic axon density in mild cognitive impairment and early Alzheimer disease
Milos D. Ikonomovic et al.
ARCHIVES OF NEUROLOGY (2007)
Cortical biochemistry in MCI and Alzheimer disease - Lack of correlation with clinical diagnosis
M. S. Forman et al.
NEUROLOGY (2007)
100 years and counting: Prospects for defeating Alzheimer's disease
Erik D. Roberson et al.
SCIENCE (2006)
Disease modifying therapy for AD?
Todd E. Golde
JOURNAL OF NEUROCHEMISTRY (2006)
Postmortem indices linking risk factors to cognition - Results from the religious order study and the memory and aging project
David A. Bennett
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2006)
Neuropathology of older persons without cognitive impairment from two community-based studies
D. A. Bennett et al.
NEUROLOGY (2006)
Differential expression of synaptic proteins in the frontal and temporal cortex of elderly subjects with mild cognitive impairment
Scott E. Counts et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
The precuneus: a review of its functional anatomy and behavioural correlates
AE Cavanna et al.
BRAIN (2006)
Decision rules guiding the clinical diagnosis of Alzheimer's disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study
David A. Bennett et al.
NEUROEPIDEMIOLOGY (2006)
Cortical control of visually guided reaching: Evidence from patients with optic ataxia
HO Karnath et al.
CEREBRAL CORTEX (2005)
Glutathione S-transferase PI *C allelic variant increases susceptibility for late-onset Alzheimer disease:: Association study and relationship with apolipoprotein E ε4 allele
S Bernardini et al.
CLINICAL CHEMISTRY (2005)
Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions
DA Bennett et al.
NEUROLOGY (2005)
Reduction of choline acetyltransferase activity in primary visual cortex in mild to moderate Alzheimer's disease
MD Ikonomovic et al.
ARCHIVES OF NEUROLOGY (2005)
Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function
DA Bennett et al.
ARCHIVES OF NEUROLOGY (2004)
Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model
F Calon et al.
NEURON (2004)
Pathways towards and away from Alzheimer's disease
MP Mattson
NATURE (2004)
Human medial intraparietal cortex subserves visuomotor coordinate transformation
C Grefkes et al.
NEUROIMAGE (2004)
The neuronal adaptor protein X11β reduces amyloid β-protein levels and amyloid plaque formation in the brains of transgenic mice
JH Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Statistics review 7: Correlation and regression
V Bewick et al.
CRITICAL CARE (2003)
The neuronal adaptor protein X11α reduces Aβ levels in the brains of Alzheimer's APPswe Tg2576 transgenic mice
JH Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Semantic and episodic memory of music are subserved by distinct neural networks
H Platel et al.
NEUROIMAGE (2003)
Loss of calbindin-D28K from aging human cholinergic basal forebrain:: Relation to plaques and tangles
C Geula et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
Brain activations during motor imagery of locomotor-related tasks: A PET study
F Malouin et al.
HUMAN BRAIN MAPPING (2003)
Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment
AL Guillozet et al.
ARCHIVES OF NEUROLOGY (2003)
Apolipoprotein E ε4 allele, AD pathology, and the clinical expression of Alzheimer's disease
DA Bennett et al.
NEUROLOGY (2003)
Alzheimer's disease is a synaptic failure
DJ Selkoe
SCIENCE (2002)
Natural history of mild cognitive impairment in older persons
DA Bennett et al.
NEUROLOGY (2002)
Individual differences in rates of change in cognitive abilities of older persons
RS Wilson et al.
PSYCHOLOGY AND AGING (2002)
Progressive reduction of synaptophysin message in single neurons in Alzheimer disease
LM Callahan et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2002)
Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment
ST DeKosky et al.
ANNALS OF NEUROLOGY (2002)
Topographical layout of hand, eye, calculation, and language-related areas in the human parietal lobe
O Simon et al.
NEURON (2002)
Brain systems engaged in encoding and retrieval of word-pair associates independent of their imagery content or presentation modalities
D Schmidt et al.
NEUROPSYCHOLOGIA (2002)
Synaptic pathology in prefrontal cortex is present only with severe dementia in Alzheimer disease
SL Minger et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2001)
Oligodendroglial tau filament formation in transgenic mice expressing G272V tau
J Götz et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2001)
Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease
E Masliah et al.
NEUROLOGY (2001)
The decline in synapses and cholinergic activity is asynchronous in Alzheimer's disease
P Tiraboschi et al.
NEUROLOGY (2000)
Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein
A Probst et al.
ACTA NEUROPATHOLOGICA (2000)
The cholinergic deficit coincides with Aβ deposition at the earliest histopathologic stages of Alzheimer disease
TG Beach et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2000)
Correlation between elevated levels of amyloid β-peptide in the brain and cognitive decline
J Näslund et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
